advertisement

Diabetes

19 July 2010

Confer with doc about Avandia use

Several medical organisations have urged patients not to change their Avandia medication before consulting a health-care professional.

One day after a US advisory panel recommended that the controversial diabetes drug Avandia stay on the market - albeit with added restrictions - several medical organisations are urging patients not to change their medications before consulting a health-care professional.

Actos (pioglitazone) is a drug similar to Avandia, one of the same class of medications known as thiazolidinediones (TZDs).

Risk of heart attacks

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Diabetes expert

Dr. May currently works as a fulltime endocrinologist and has been in private practice since 2004. He has a variety of interests, predominantly obesity and diabetes, but also sees patients with osteoporosis, thyroid disorders, men's health disorders, pituitary and adrenal disorders, polycystic ovaries, and disorders of growth. He is a leading member of several obesity and diabetes societies and runs a trial centre for new drugs.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules